Literature DB >> 12807720

The role of P-glycoprotein in intestinal tumorigenesis: disruption of mdr1a suppresses polyp formation in Apc(Min/+) mice.

Yasushi Mochida1, Ken-ichi Taguchi, Shuichi Taniguchi, Masazumi Tsuneyoshi, Hiroyuki Kuwano, Teruhisa Tsuzuki, Michihiko Kuwano, Morimasa Wada.   

Abstract

P-glycoprotein (P-gp) mediates the active transport of various substrates including xenobiotics, and it thus has a protective function in various cell types and tissues/organs including the intestinal epithelium. However, whether or not P-gp plays a positive role in the intestinal tumorigenesis is unclear. We have introduced disrupted alleles of the murine P-gp gene, mdr1a, into Apc(Min/+) mice to evaluate whether P-gp plays any role in intestinal carcinogenesis. Spontaneously occurring DNA damage was significantly increased in both the small and large intestine of mdr1a(-/-), Apc(Min/+) mice compared with mdr1a(+/+), Apc(Min/+) mice. Furthermore, we observed active proliferation and rapid migration/disappearance of enterocytes in the intestine of the compound mice deficient in mdr1a. Finally, we found that the number of polyps and cancers was markedly decreased in mdr1a(-/-), Apc(Min/+) mice (P=0.0016). P-gp thus appears to play a positive role during intestinal tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12807720     DOI: 10.1093/carcin/bgg073

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  18 in total

1.  No association between MDR1 (ABCB1) 2677G>T and 3435C>T polymorphism and sporadic colorectal cancer among Bulgarian patients.

Authors:  Darinka Todorova Petrova; Petya Nedeva; Svilen Maslyankov; Svetoslav Toshev; Nikolay Yaramov; Srebrena Atanasova; Draga Toncheva; Michael Oellerich; Nicolas von Ahsen
Journal:  J Cancer Res Clin Oncol       Date:  2007-08-03       Impact factor: 4.553

2.  Assessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal versus distal colorectum.

Authors:  Mai Yamauchi; Teppei Morikawa; Aya Kuchiba; Yu Imamura; Zhi Rong Qian; Reiko Nishihara; Xiaoyun Liao; Levi Waldron; Yujin Hoshida; Curtis Huttenhower; Andrew T Chan; Edward Giovannucci; Charles Fuchs; Shuji Ogino
Journal:  Gut       Date:  2012-03-17       Impact factor: 23.059

3.  Oncogenic retinoic acid receptor γ knockdown reverses multi-drug resistance of human colorectal cancer via Wnt/β-catenin pathway.

Authors:  Gui-Li Huang; Wei Song; Pan Zhou; Qi-Rui Fu; Chen-Lu Lin; Qing-Xi Chen; Dong-Yan Shen
Journal:  Cell Cycle       Date:  2017-03-08       Impact factor: 4.534

4.  Dual infection with Helicobacter bilis and Helicobacter hepaticus in p-glycoprotein-deficient mdr1a-/- mice results in colitis that progresses to dysplasia.

Authors:  Lillian Maggio-Price; Helle Bielefeldt-Ohmann; Piper Treuting; Brian M Iritani; Weiping Zeng; Andrea Nicks; Mark Tsang; Donna Shows; Phil Morrissey; Joanne L Viney
Journal:  Am J Pathol       Date:  2005-06       Impact factor: 4.307

5.  Role of microRNAs in resveratrol-mediated mitigation of colitis-associated tumorigenesis in Apc(Min/+) mice.

Authors:  Ibrahim Altamemi; E Angela Murphy; James F Catroppo; Elizabeth E Zumbrun; Jiajia Zhang; Jamie L McClellan; Udai P Singh; Prakash S Nagarkatti; Mitzi Nagarkatti
Journal:  J Pharmacol Exp Ther       Date:  2014-05-09       Impact factor: 4.030

6.  ABCB1/MDR1 gene polymorphisms as a prognostic factor in colorectal cancer.

Authors:  Ewa Balcerczak; Mariusz Panczyk; Sylwester Piaskowski; Grazyna Pasz-Walczak; Aleksandra Sałagacka; Marek Mirowski
Journal:  Int J Colorectal Dis       Date:  2010-06-09       Impact factor: 2.571

7.  Involvement of multidrug resistance-associated protein 1 in intestinal toxicity of methotrexate.

Authors:  Sayaka Kato; Katsuaki Ito; Yukio Kato; Tomohiko Wakayama; Yoshiyuki Kubo; Shoichi Iseki; Akira Tsuji
Journal:  Pharm Res       Date:  2009-03-14       Impact factor: 4.200

8.  Tissue distribution, gender-divergent expression, ontogeny, and chemical induction of multidrug resistance transporter genes (Mdr1a, Mdr1b, Mdr2) in mice.

Authors:  Yue Julia Cui; Xingguo Cheng; Yi Miao Weaver; Curtis D Klaassen
Journal:  Drug Metab Dispos       Date:  2008-10-14       Impact factor: 3.922

9.  ABC transporters in cancer: more than just drug efflux pumps.

Authors:  Jamie I Fletcher; Michelle Haber; Michelle J Henderson; Murray D Norris
Journal:  Nat Rev Cancer       Date:  2010-01-15       Impact factor: 60.716

10.  ABCB1 gene polymorphisms and haplotype analysis in colorectal cancer.

Authors:  Mariusz Panczyk; Ewa Balcerczak; Sylwester Piaskowski; Krzysztof Jamroziak; Grazyna Pasz-Walczak; Marek Mirowski
Journal:  Int J Colorectal Dis       Date:  2009-05-05       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.